Friday, April 10, 2026

Wegovy Gets Stronger: New Dose Promises Even More Weight Loss

Novo Nordisk's new high-dose Wegovy aims to enhance obesity treatment, with promising trial results and a strategic EU rollout planned.

North Korea Says ‘No Thanks’ to YouTubers and Journalists at Trade Fair

North Korea restricts journalists and influencers from attending the Pyongyang International Trade Fair, limiting exposure to negative content.

South Korean Military Strengthens Defense with Full Operationalization of 425 Project Satellites

South Korea's military will launch five reconnaissance satellites by 2025, enhancing capabilities to monitor North Korea's activities.

Tag: Jeon In-seok

Samchundang Pharma CEO Claims FDA Recognition for Obesity Drug as Generic

Samchundang Pharma's CEO announces FDA recognition of oral semaglutide as a generic and withdraws $1.7 billion stock sale plan.

Top News

- Our Sponsors Ad -

Follow us